| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
| 07/31/2003 | US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/31/2003 | CA2473763A1 Compounds for modulating cell proliferation |
| 07/31/2003 | CA2455844A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 07/30/2003 | EP1330292A2 Radioactive member for use in brachytherapy and method of making |
| 07/30/2003 | EP1330233A1 Method of treating stroke |
| 07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/30/2003 | EP1123287B1 Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles |
| 07/30/2003 | EP0592439B1 Aminosulfonyl carbamates |
| 07/30/2003 | CN1433420A Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof |
| 07/30/2003 | CN1433404A Hydroxypyridone methide azo dyes |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433297A Topical compositions comprising protected functional thiols |
| 07/30/2003 | CN1432571A Pyridone compound and its prepn process |
| 07/30/2003 | CN1116366C Pyridone-methide azo dyestuffs |
| 07/30/2003 | CN1116283C Cyanoguanidines as well proliferation inhibitors |
| 07/30/2003 | CN1116282C Bisulfate salt of HIV protease inhibitor |
| 07/30/2003 | CN1116277C Process for preparing carbocylic or heterocyclic nitriles by vapor phase ammoxidation |
| 07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
| 07/30/2003 | CN1116037C Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6600046 Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfony)phenyl]ethanone |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599942 Method of lowering LDL cholesterol and Lipoprotein a levels in mammals using such compounds |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599590 Unsaturated fluorine compound |
| 07/29/2003 | CA2247398C Herbicidal sulfonamide derivatives |
| 07/29/2003 | CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 07/29/2003 | CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives |
| 07/24/2003 | WO2003060015A1 Yellow cationic dyes for dying of organic material |
| 07/24/2003 | WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | WO2003059903A2 Substituted 4-aminopyridine derivatives used as pest control agents |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 07/24/2003 | WO2003059346A1 Beta-secretase inhibitors |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059258A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | US20030139445 Method for treating retroviral infections |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | US20030139408 Analgesics; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139390 Compounds for the modulation of PPARgamma activity |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product |
| 07/24/2003 | CA2700690A1 Process for producing reformatsky reagent in stable form |
| 07/24/2003 | CA2473441A1 Beta-secretase inhibitors |
| 07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | CA2472993A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | CA2471311A1 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | CA2469435A1 Modulators of lxr |
| 07/23/2003 | EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/23/2003 | EP1328504A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 07/23/2003 | EP1328499A2 Method of producing carboxylic acid salts |
| 07/23/2003 | EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 07/23/2003 | EP1230240B1 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 07/23/2003 | CN1432000A TNF-alpha prodn. inhibitors |
| 07/23/2003 | CN1431198A New method for preparing 3-pyridine acetic hydrochloride |
| 07/23/2003 | CN1431197A Alanine class compound, its preparing method and use |
| 07/23/2003 | CN1115334C Pyridine derivative and pharmaceutical contg. same |
| 07/23/2003 | CN1115333C Method for producing 2-sulfonylpyridine derivatives and method for producing 2-´¢øÒÇö(2-pyridyl)methylÒÇòthio´¢Ø-1H-benzimidazole derivatives |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/23/2003 | CN1115141C In-situ generation of zinc pyrithione |
| 07/22/2003 | US6596872 Process for preparing alkenyl-substituted heterocycles |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596773 Central nervous system disorders |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596737 C10 carbamoyloxy substituted taxanes |
| 07/22/2003 | US6596736 Well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non- toxic therapeutically effective amount of a compound of Formula I. pain, dysmenorrhea, myositis, |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells |
| 07/22/2003 | US6596193 Reactive liquid crystal compounds; improves switching times especially at low temperatures |
| 07/22/2003 | CA2276203C N-(pyridinylamino)isoindolines and related compounds |
| 07/17/2003 | WO2003057664A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |